Literature DB >> 21253096

Non-invasive prenatal testing.

B C McGillivray.   

Abstract

Non-invasive modalities to assess the ongoing pregnancy may assist the clinician to identify risk factors requiring additions or alteration to routine prenatal care. These modalities include pedigree analysis, maternal serum alphafetoprotein screening, fetal ultrasonography, and Doppler ultrasound. These methods should be used when there are appropriate clinical indications and awareness of their limitations.

Year:  1988        PMID: 21253096      PMCID: PMC2218979     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  9 in total

1.  Screening for maternal serum alpha-fetoprotein: what about the low side?

Authors:  A Lippman; J A Evans
Journal:  CMAJ       Date:  1987-04-15       Impact factor: 8.262

2.  Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.

Authors:  T A Doran; G H Valentine; P Y Wong; G Wielgosz; R J Benzie; H C Soltan; M R Jenner; P A Morland; R J Montgomery; L C Allen
Journal:  CMAJ       Date:  1987-08-15       Impact factor: 8.262

Review 3.  The umbilical circulation.

Authors:  B J Trudinger
Journal:  Semin Perinatol       Date:  1987-10       Impact factor: 3.300

4.  Umbilical artery flow velocity waveforms in high-risk pregnancy. Randomised controlled trial.

Authors:  B J Trudinger; C M Cook; W B Giles; A Connelly; R S Thompson
Journal:  Lancet       Date:  1987-01-24       Impact factor: 79.321

5.  Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.

Authors:  N J Wald; H Cuckle; J H Brock; R Peto; P E Polani; F P Woodford
Journal:  Lancet       Date:  1977-06-25       Impact factor: 79.321

6.  Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study.

Authors:  J A Goldman; D Dicker; D Feldberg; A Yeshaya; N Samuel; M Karp
Journal:  Am J Obstet Gynecol       Date:  1986-08       Impact factor: 8.661

Review 7.  Systemic lupus erythematosus in pregnancy.

Authors:  J P Hayslett; E A Reece
Journal:  Clin Perinatol       Date:  1985-10       Impact factor: 3.430

8.  Timing of strict diet in relation to fetal damage in maternal phenylketonuria. An international collaborative study by the MRC/DHSS Phenylketonuria Register.

Authors:  E Drogari; I Smith; M Beasley; J K Lloyd
Journal:  Lancet       Date:  1987-10-24       Impact factor: 79.321

9.  An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities.

Authors:  I R Merkatz; H M Nitowsky; J N Macri; W E Johnson
Journal:  Am J Obstet Gynecol       Date:  1984-04-01       Impact factor: 8.661

  9 in total
  1 in total

1.  Neonatal screening part 1. General principles.

Authors:  B A Morris
Journal:  Can Fam Physician       Date:  1990-01       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.